CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6

References

• BORN, S. L., CAUDILL, D., FLITER, K. L. and PURDON, M. P., 2002, Identification of the cytochromes p450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metabolism and Disposition, 30, 483–487.
   PubMed Web of Science ®Google Scholar
• BORN, S. L., Hu, J. K. and LEHMAN-MCKEEMAN, L. D., 2000, o-Hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. Drug Metabolism and Disposition, 28, 218–223.
   Google Scholar
• BORN, S. L., RODRIGUEZ, P. A., EDDY, C. L. and LEHMANN-MCKEEMAN, L. D., 1997, Synthesis and reactivity of coumarin 3,4-epoxide. Drug Metabolism and Disposition, 25, 1318–1323.
   Google Scholar
• CRAWFORD, E. L., WEAVER, D. A., DEMUTH, J. P., JACKSON, D. M., KHUDER, S. A., FRAMPTON, M. W., UTELL, M. J., THILLY, W. G. and WILLEY, J. C., 1998, Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis, 19, 1867–1871.
   PubMed Web of Science ®Google Scholar
• DING, S., LAKE, B. G., FRIEDBERG, T. and WOLF, C. R., 1995, Expression and alternative splicing of the cytochrome P450 CYP2A6. Biochemical Journal, 306, 161–166.
   PubMed Web of Science ®Google Scholar
• EGAN, D. A. and O'KENNEDY, R., 1992, Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high-performance liquid chromatography. Journal of Chromatographic and Biomedical Applications, 582, 137–143.
   Google Scholar
• FELICIA, N. D., REKHA, G. K. and MURPHY, S. E., 2000, Characterization of cytochrome P450 2A4 and 2A5 catalyzed 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) metabolism. Archives of Biochemistry and Biophysics, 384, 418–424.
   PubMed Web of Science ®Google Scholar
• FENTEM, J. H. and FRY, J. R., 1993, Species differences in the metabolism and hepatotoxicity of coumarin. Comparative Biochemistry and Physiology, 104C, 1–8.
   Google Scholar
• FERNANDEZ-SALGUERO, P., HOFFMAN, S., CHOLERTON, S., MOHRENVVEISER, H., RAUNIO, H., RAUTIO, H., PELKONEN, O., HUANG, J. D., EVANS, W., IDLE, J. and GONZALEZ, F., 1995, A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Human Genetics, 57, 651–660.
   Google Scholar
• HECHT, S. S., 1998, Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559–603.
   PubMed Web of Science ®Google Scholar
• HONKAKOSKI, P. and NEGISHI, M., 1997, The structure, function, and regulation of cytochrome P450 2A enzymes. Drug Metabolism Reviews, 29, 977–996.
   PubMed Web of Science ®Google Scholar
• KOSKELA, S., HAKKOLA, J., HUKKANEN, J., PELKONEN, O., SORRI, M., SARANEN, A., ANTTILA, S., FERNANDEZ-SALGUERO, P., GONZALEZ, F. and RAUNIO, H., 1999, Expression of CYP2A genes in human liver and extrahepatic tissues. Biochemical Pharmacology, 57, 1407–1413.
   Google Scholar
• LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of mouse cytochrome P450(coh) substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
   Google Scholar
• MILES, J. S., MCLAREN, A. W., FORRESTER, L. M., GLANCEY, M. J., LANG, M. A. and WOLF, C. R., 1990, Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal, 267, 365–371.
   PubMed Web of Science ®Google Scholar
• NEGISHI, M., LINDBERG, R., BURKHART, B., ICHIKAWA, T., HONKAKOSKI, P. and LANG, M., 1989, Mouse steroid 15alpha-hydroxylase gene family: identification of type II P-450 15alpha as coumarin 7-hydroxylase. Biochemistry, 28, 4169–4172.
   PubMed Web of Science ®Google Scholar
• PATTEN, C. J., SMITH, T. J., MURPHY, S. E., WANG, M. H., LEE, J., TYNES, R. E., KOCH, P. and YANG, C. S., 1996, Kinetic analysis of activation of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone by heterologously expressed human P450 enzymes, and the effect of P450 specific chemical inhibitors on this activation in human liver microsomes. Archives of Biochemistry and Biophysics, 333, 127–138.
   PubMed Web of Science ®Google Scholar
• PATTEN, C. J., SMITH, T. J., TYNES, R., FRIESEN, M., LEE, J., YANG, C. S. and MURPHY, S. E., 1997, Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine hydroxylation in human liver microsomes. Carcinogenesis, 18, 1623–1628.
   PubMed Web of Science ®Google Scholar
• PERRELLA, F. W., 1988, EZ-FIT: a practical curve fitting microcomputer program for the analysis of enzyme kinetics on IBM-PC computers. Analytical Biochemistry, 174, 437–447.
   PubMed Web of Science ®Google Scholar
• SHILLING, W. H., CRAMPTON, R. F. and LONGLAND, R. C., 1969, Metabolism of coumarin in man. Nature, 221, 664–665.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome p450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SU, T., BAO, Z., ZHANG, Q. Y., SMITH, T. J., HONG, J. Y. and DING, X., 2000, Human cytochrome P 450 CYP2A13: Predominant expression in the respiratory tract and in high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone. Cancer Research, 60, 5074–5079.
   PubMed Web of Science ®Google Scholar
• VON WEYMARN, L. B., FELICIA, N. D., DING, X. and MURPHY, S. E., 1999, N-Nitrosobenzylmethylamine a-hydroxylation and coumarin 7-hydroxylation by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes. Chemical Research in Toxicology, 12, 1254–1261.
   PubMed Web of Science ®Google Scholar
• VON WEYMARN, L. B. and MURPHY, S. E., 2001, Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3. Chemical Research in Toxicology, 14, 1386–1392.
   PubMed Web of Science ®Google Scholar
• YAMANO, S., TATSUNO, J. and GONZALEZ, F. J., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322–1329.
   PubMed Web of Science ®Google Scholar
• YUN, C. H., SHIMADA, T. and GUENGERICH, F. P., 1991, Purification and characterization of human liver microsomal cytochrome P-450 2A6. Molecular Pharmacology, 40, 679–685.
   PubMed Web of Science ®Google Scholar
• ZHUO, X., GU, J., ZHANG, Q. Y., SPINK, D. C., KAMINSKY, L. S. and DING, X., 1999, Biotransformation of coumarin by rodent and human cytochrome P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice. Journal of Pharmacology and Experimental Therapeutics, 288, 463–471.
   PubMed Web of Science ®Google Scholar